Showing results (11-20 of 127) with videos related to
Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2005
Stargazin is an AMPA receptor auxiliary subunitWim Vandenberghe, Roger A Nicoll, David S BredtJournal of Neurology|March 10, 2009
Diffusion-weighted versus volumetric imaging of the striatum in early symptomatic Huntington diseaseWim Vandenberghe, Philippe Demaerel, René Dom, et al.Current Opinion in Critical Care|October 15, 2014
Contrast-associated AKI in the critically ill: relevant or irrelevant?Wim Vandenberghe, Wouter De Corte, Eric A J HosteCurrent Opinion in Anaesthesiology|December 2, 2016
Diagnosis of cardiac surgery-associated acute kidney injury from functional to damage biomarkersWim Vandenberghe, Jorien De Loor, Eric A J HosteNeuroreport|March 26, 2009
Deep brain stimulation modulates effects of motivation in Parkinson's diseasePaul Sauleau, Alexandre Eusebio, Wim Vandenberghe, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 30, 2025
Normal [<sup>18</sup>F]FE-PE2I PET in Patients with Persistent Diagnostic Uncertainty after Abnormal [<sup>123</sup>I]FP-CIT SPECTMichiel Dhadamus, Aline Delva, Wies Deckers, et al.Neurology|October 27, 2012
Determinants of fitness to drive in Huntington diseaseHannes Devos, Alice Nieuwboer, Mark Tant, et al.The European Journal of Neuroscience|January 15, 2008
Parkin occurs in a stable, non-covalent, approximately 110-kDa complex in brainCindy Van Humbeeck, Etienne Waelkens, Olga Corti, et al.Brain Sciences|May 27, 2026
Combined Striatal Dopaminergic and Cardiac Sympathetic Imaging in Parkinson's DiseaseLouis Versweyveld, Greet Vanderlinden, Wim Vandenberghe, et al.Neurology|October 19, 2021
Synaptic Damage and Its Clinical Correlates in People With Early Huntington Disease: A PET StudyAline Delva, Laura Michiels, Michel Koole, et al.Pageof 13